Electromed, Inc. (ELMD) Spending and interest coverage
- R&D / revenue · 12 months: Value 1.78%; Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value 3.69%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | 1.78% | Research and development expense / revenue. Period ending 2026-06-30. $1.31M ÷ $73.78M × 100 ≈ 1.78% |
| Stock-based compensation / revenue · 12 months | 3.69% | Share-based compensation / revenue. Period ending 2026-06-30. $2.72M ÷ $73.78M × 100 ≈ 3.69% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | 1.31M USD | Research and Development Expense |
| Revenue | 73.78M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 2.72M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | 13.88M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.31M | $73.78M | $2.72M | $13.88M | (m) | 1.78% | 3.69% | (m) | (m) |
| 2026-03-31 | $1.29M | $71.75M | $2.61M | $13.10M | (m) | 1.80% | 3.64% | (m) | (m) |
| 2025-12-31 | $1.20M | $68.86M | $2.52M | $11.47M | (m) | 1.75% | 3.66% | (m) | (m) |
| 2025-09-30 | $1.07M | $66.22M | $2.82M | $10.39M | (m) | 1.62% | 4.26% | (m) | (m) |
| 2025-06-30 | $996.00K | $64.00M | $3.06M | $9.66M | (m) | 1.56% | 4.78% | (m) | (m) |
| 2025-03-31 | $870.00K | $61.44M | $2.85M | $8.96M | (m) | 1.42% | 4.64% | (m) | (m) |
| 2024-12-31 | $760.00K | $59.63M | $2.55M | $8.66M | (m) | 1.27% | 4.28% | (m) | (m) |
| 2024-09-30 | $616.00K | $57.06M | $2.02M | $8.38M | (m) | 1.08% | 3.54% | (m) | (m) |
| 2024-06-30 | $656.00K | $54.72M | $1.69M | $6.58M | (m) | 1.20% | 3.09% | (m) | (m) |
| 2024-03-31 | $778.00K | $53.50M | $1.45M | $5.74M | (m) | 1.45% | 2.71% | (m) | (m) |
| 2023-12-31 | $777.00K | $51.69M | $1.18M | $5.09M | (m) | 1.50% | 2.29% | (m) | (m) |
| 2023-09-30 | $824.00K | $49.73M | $984.00K | $4.11M | (m) | 1.66% | 1.98% | (m) | (m) |
| 2023-06-30 | $916.00K | $48.07M | $708.00K | $4.01M | (m) | 1.91% | 1.47% | (m) | (m) |
| 2023-03-31 | $933.00K | $45.72M | $779.00K | $3.01M | (m) | 2.04% | 1.70% | (m) | (m) |
| 2022-12-31 | $1.10M | $43.80M | $766.00K | $2.68M | (m) | 2.52% | 1.75% | (m) | (m) |
| 2022-09-30 | $1.28M | $42.32M | $822.00K | $2.48M | (m) | 3.02% | 1.94% | (m) | (m) |
| 2022-06-30 | $1.36M | $41.66M | $976.00K | $2.97M | (m) | 3.25% | 2.34% | (m) | (m) |
| 2022-03-31 | $1.37M | $39.86M | $971.00K | $3.13M | (m) | 3.43% | 2.44% | (m) | (m) |
| 2021-12-31 | $1.44M | $38.51M | $1.12M | $2.51M | (m) | 3.73% | 2.91% | (m) | (m) |
| 2021-09-30 | $1.62M | $37.75M | $1.08M | $3.02M | (m) | 4.28% | 2.87% | (m) | (m) |
| 2021-06-30 | $1.72M | $35.76M | $1.02M | $3.14M | (m) | 4.82% | 2.86% | (m) | (m) |
| 2021-03-31 | $1.81M | $33.16M | $981.37K | $3.78M | (m) | 5.46% | 2.96% | (m) | (m) |
| 2020-12-31 | $1.80M | $33.12M | $887.45K | $4.45M | (m) | 5.42% | 2.68% | (m) | (m) |
| 2020-09-30 | $1.43M | $32.17M | $883.08K | $4.43M | (m) | 4.45% | 2.74% | (m) | (m) |
| 2020-06-30 | $1.05M | $32.47M | $901.93K | $5.12M | (m) | 3.23% | 2.78% | (m) | (m) |
| 2020-03-31 | $740.90K | $34.20M | $871.16K | $5.31M | (m) | 2.17% | 2.55% | (m) | (m) |
| 2019-12-31 | $519.70K | $32.86M | $867.58K | $4.86M | (m) | 1.58% | 2.64% | (m) | (m) |
| 2019-09-30 | $614.06K | $32.33M | $876.79K | $3.97M | (m) | 1.90% | 2.71% | (m) | (m) |
| 2019-06-30 | $583.31K | $31.30M | $924.07K | $2.82M | (m) | 1.86% | 2.95% | (m) | (m) |
| 2019-03-31 | $558.11K | $30.96M | $988.09K | $2.89M | (m) | 1.80% | 3.19% | (m) | (m) |
| 2018-12-31 | $430.01K | $30.72M | $977.17K | $3.01M | (m) | 1.40% | 3.18% | (m) | (m) |
| 2018-09-30 | $248.92K | $29.67M | $929.52K | $3.11M | (m) | 0.84% | 3.13% | (m) | (m) |
| 2018-06-30 | $251.44K | $28.70M | $862.67K | $3.01M | (m) | 0.88% | 3.01% | (m) | (m) |
| 2018-03-31 | $234.74K | $27.73M | $709.63K | $2.93M | (m) | 0.85% | 2.56% | (m) | (m) |
| 2017-12-31 | $272.69K | $27.31M | $631.10K | $3.48M | (m) | 1.00% | 2.31% | (m) | (m) |
| 2017-09-30 | $316.62K | $26.70M | $560.66K | $3.44M | (m) | 1.19% | 2.10% | (m) | (m) |
| 2017-06-30 | $596.88K | $25.86M | $479.48K | $3.57M | (m) | 2.31% | 1.85% | (m) | (m) |
| 2017-03-31 | $729.60K | $24.28M | $443.21K | $2.59M | (m) | 3.00% | 1.83% | (m) | (m) |
| 2016-12-31 | $733.40K | $23.65M | $348.23K | $2.29M | (m) | 3.10% | 1.47% | (m) | (m) |
| 2016-09-30 | $689.69K | $23.54M | $292.82K | $2.81M | (m) | 2.93% | 1.24% | (m) | (m) |
| 2016-06-30 | $380.39K | $22.99M | $222.76K | $3.11M | (m) | 1.65% | 0.97% | (m) | (m) |
| 2016-03-31 | $261.49K | $22.50M | $185.22K | $2.98M | (m) | 1.16% | 0.82% | (m) | (m) |
| 2015-12-31 | $255.37K | $21.02M | $181.00K | $2.30M | (m) | 1.21% | 0.86% | (m) | (m) |
| 2015-09-30 | $281.93K | $19.64M | $134.41K | $1.50M | $85.46K | 1.44% | 0.68% | 17.52× | Reported |
| 2015-06-30 | $315.65K | $19.41M | $110.35K | $1.31M | $85.71K | 1.63% | 0.57% | 15.29× | Reported |
| 2015-03-31 | $298.25K | $18.82M | $87.00K | $1.27M | $86.49K | 1.58% | 0.46% | 14.63× | Reported |
| 2014-12-31 | $323.13K | $18.22M | $55.33K | $990.77K | $89.46K | 1.77% | 0.30% | 11.07× | Reported |
| 2014-09-30 | $332.22K | $16.84M | $57.86K | $234.59K | $84.25K | 1.97% | 0.34% | 2.78× | Reported |
| 2014-06-30 | $466.06K | $15.49M | $82.23K | $-740.59K | $79.00K | 3.01% | 0.53% | -9.37× | Reported |
| 2014-03-31 | $696.49K | $14.89M | $117.44K | $-1.54M | $83.20K | 4.68% | 0.79% | -18.57× | Reported |
| 2013-12-31 | $694.78K | $14.14M | $154.83K | $-2.02M | $89.04K | 4.91% | 1.10% | -22.71× | Reported |
| 2013-09-30 | $711.29K | $14.49M | $173.94K | $-2.31M | $95.35K | 4.91% | 1.20% | -24.21× | Reported |
| 2013-06-30 | $603.38K | $15.10M | $175.80K | $-1.83M | $116.88K | 3.99% | 1.16% | -15.63× | Reported |
| 2013-03-31 | $527.01K | $15.67M | $170.74K | $-1.56M | $130.21K | 3.36% | 1.09% | -11.96× | Reported |
| 2012-12-31 | $663.78K | $17.24M | $159.88K | $-638.05K | $143.74K | 3.85% | 0.93% | -4.44× | Reported |
| 2012-09-30 | $804.87K | $18.18M | $145.87K | $57.51K | $161.55K | 4.43% | 0.80% | 0.36× | Reported |
| 2012-06-30 | $920.77K | $19.52M | $135.60K | $606.34K | $168.73K | 4.72% | 0.69% | 3.59× | Reported |
| 2012-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | $1.03M | $19.00M | $156.17K | $1.87M | $191.33K | 5.44% | 0.82% | 9.77× | Reported |
| 2011-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EDAP TMS SA (FOCL) | $0.171B | ||
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B |